PubMed:23973 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/23973","sourcedb":"PubMed","sourceid":"23973","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/23973","text":"Oxypertine in combination with imipramine: a controlled trial.\nA method for the controlled assessment of two agents for possible interaction in the treatment of endogenous depression is described. This consisted of dose-ranging the supplementary agent (oxypertine 30 mg and 60 mg daily or matching placebo) during Week 2 to Week 6 having established all patients on a therapeutic dose of imipramine during Week 1. The reported enhancement of imipramine by oxypertine was not confirmed.","tracks":[{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":172,"end":182},"obj":"HP_0000716"}],"attributes":[{"subj":"T1","pred":"source","obj":"PubmedHPO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"PubmedHPO","color":"#9f93ec","default":true}]}]}}